Skip to main content
Premium Trial:

Request an Annual Quote

Waters Q2 Organic Sales Grow 8 Percent, Though Profit Slides 10 Percent

NEW YORK, July 26 (GenomeWeb News) - Waters today said that second-quarter sales increased around 8 percent organically atop increasing R&D spending and a 10-percent slide in net profits.

 

Still, the company's stock was up more than 9 percent, or $3.80, at $44.50 in heavy trading Tuesday afternoon because the profit beat analysts' consensus estimate.

 

Total sales for the period ended July 2 increased 9 percent to $284.6 million from $260.5 million year over year, Waters said. Approximately 1 percent of the growth was the result of favorable foreign-currency exchange rates.

 

R&D spending in the period increased around 5 percent to $16.5 million from $15.7 million in the year-ago quarter.

 

Net income, however, slid almost 10 percent to $54 million, or $.47 per basic share, from $59.8 million, or $.50 per basic share, year over year.

 

Waters said it had around $615 million in cash and equivalents as of July 2.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.